DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 0.17% to $743.35 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 5,917.11 and the Dow Jones Industrial Average rising 0.32% to 43,408.47.
This was the stock's second consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed $467.85 below its 52-week high ($1,211.20), which the company reached on August 27th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 2.83% to $287.87, Moderna Inc. $(MRNA)$ fell 0.94% to $36.94, and Gilead Sciences Inc. $(GILD)$ rose 1.00% to $88.63.
Trading volume (654,394) remained 112,151 below its 50-day average volume of 766,545.
Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 20, 2024 16:45 ET (21:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments